Zantac pulled from shelves after concerns about carcinogen
Heartburn medication Zantac is being recalled in the U.S. and Canada amid worries that it may be tainted with possible cancer causing chemical
Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity.